CD109 and squamous cell carcinoma

Squamous cell carcinoma (SCC) is well-known for its high rate of metastasis with poor prognosis. CD109 is a glycosylphosphatidylinositol-anchored cell-surface glycoprotein. Recently, CD109 emerges as a potential biomarker and a therapeutic target for SCCs. Accumulating studies have reported that CD1...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Ruixia, Dong, Fengyun, Liu, Qiang, Murakumo, Yoshiki, Liu, Ju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889571/
https://www.ncbi.nlm.nih.gov/pubmed/29625613
http://dx.doi.org/10.1186/s12967-018-1461-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889571/
https://www.ncbi.nlm.nih.gov/pubmed/29625613
http://dx.doi.org/10.1186/s12967-018-1461-3

Ejemplares similares